“罕见病“一词译自英语“rare disease“。在全球权威的生物医学数据库PubMed中,“rare disease“一词最早出现在1867年。与“常见病“相对,“罕见病“是指患病率较低的一类疾病。罕见病,又称“孤儿病”。根据世界卫生组织定义,罕见病是指患病人数占总人口0.65‰~1‰之间的疾病或病变。目前,全球罕见病约有7000多种,包括渐冻症、“玻璃人”(血友病)、“木偶人”(多发性硬化症)、松软儿(脊髓性肌萎缩症)等。罕见病不只是一个医学问题,更是一个社会问题。我国罕见病患者约2000万人,每年新增患者超过20万人。他们经历着常人无法理解的痛苦,承受着非常沉重的经济负担。
国卫医发〔2018〕10号
各省、自治区、直辖市及新疆生产建设兵团卫生计生委、科技厅(委、局)、工业和信息化主管部门、食品药品监督管理局、中医药管理局:
为贯彻落实中共中央办公厅、国务院办公厅《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》,加强我国罕见病管理,提高罕见病诊疗水平,维护罕见病患者健康权益,国家卫生健康委员会等5部门联合制定了《第一批罕见病目录》。现印发你们,供各部门在工作中参考使用。
国家卫生健康委员会 科学技术部
工业和信息化部 国家药品监督管理局
国家中医药管理局
2018年5月11日
第一批罕见病目录
序号 |
中文名称 |
英文名称 |
1 |
21-Hydroxylase Deficiency |
|
2 |
Albinism |
|
3 |
Alport Syndrome |
|
4 |
Amyotrophic Lateral Sclerosis |
|
5 |
Angelman Syndrome |
|
6 |
Arginase Deficiency |
|
7 |
Asphyxiating Thoracic Dystrophy (Jeune Syndrome) |
|
8 |
Atypical Hemolytic Uremic Syndrome |
|
9 |
Autoimmune Encephalitis |
|
10 |
Autoimmune Hypophysitis |
|
11 |
Autoimmune Insulin Receptopathy (Type B insulin resistance) |
|
12 |
Beta-ketothiolase Deficiency |
|
13 |
Biotinidase Deficiency |
|
14 |
Cardic Ion Channelopathies |
|
15 |
Carnitine Deficiency |
|
16 |
Castleman Disease |
|
17 |
Charcot-Marie-Tooth Disease |
|
18 |
Citrullinemia |
|
19 |
Congenital Adrenal Hypoplasia |
|
20 |
Congenital Hyperinsulinemic Hypoglycemia |
|
21 |
Congenital Myasthenic Syndrome |
|
22 |
Congenital Myotonia Syndrome (Non-Dystrophic Myotonia, NDM) |
|
23 |
Congenital Scoliosis |
|
24 |
Coronary Artery Ectasia |
|
25 |
Diamond-Blackfan Anemia |
|
26 |
Erdheim-Chester Disease |
|
27 |
Fabry Disease |
|
28 |
Familial Mediterranean Fever |
|
29 |
Fanconi Anemia |
|
30 |
Galactosemia |
|
31 |
Gaucher’s Disease |
|
32 |
Generalized Myasthenia Gravis |
|
33 |
Gitelman Syndrome |
|
34 |
Glutaric Acidemia Type I |
|
35 |
Glycogen Storage Disease (Type I、II) |
|
36 |
Hemophilia |
|
37 |
Hepatolenticular Degeneration(Wilson Disease) |
|
38 |
Hereditary Angioedema (HAE) |
|
39 |
Hereditary Epidermolysis Bullosa |
|
40 |
Hereditary Fructose Intolerance |
|
41 |
遗传性低镁血症 |
Hereditary Hypomagnesemia |
42 |
Hereditary Multi-infarct Dementia (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, CADASIL) |
|
43 |
Hereditary Spastic Paraplegia |
|
44 |
全羧化酶合成酶缺乏症 |
Holocarboxylase Synthetase Deficiency |
45 |
Homocysteinemia |
|
46 |
Homozygous Hypercholesterolemia |
|
47 |
Huntington Disease |
|
48 |
HHH综合征 |
Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria Syndrome |
49 |
Hyperphenylalaninemia |
|
50 |
Hypophosphatasia |
|
51 |
Hypophosphatemic Rickets |
|
52 |
Idiopathic Cardiomyopathy |
|
53 |
Idiopathic Hypogonadotropic Hypogonadism |
|
54 |
Idiopathic Pulmonary Arterial Hypertension |
|
55 |
Idiopathic Pulmonary Fibrosis |
|
56 |
IgG4 related Disease |
|
57 |
先天性胆汁酸合成障碍 |
Inborn Errors of Bile Acid Synthesis |
58 |
Isovaleric Acidemia |
|
59 |
Kallmann Syndrome |
|
60 |
Langerhans Cell Histiocytosis |
|
61 |
Laron Syndrome |
|
62 |
Leber Hereditary Optic Neuropathy |
|
63 |
Long Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency |
|
64 |
Lymphangioleiomyomatosis (LAM) |
|
65 |
赖氨酸尿蛋白不耐受症 |
Lysinuric Protein Intolerance |
66 |
Lysosomal Acid Lipase Deficiency |
|
67 |
Maple Syrup Urine Disease |
|
68 |
Marfan Syndrome |
|
69 |
McCune-Albright Syndrome |
|
70 |
Medium Chain Acyl-CoA Dehydrogenase Deficiency |
|
71 |
Methylmalonic Academia |
|
72 |
Mitochodrial Encephalomyopathy |
|
73 |
Mucopolysaccharidosis |
|
74 |
Multifocal Motor Neuropathy |
|
75 |
Multiple Acyl-CoA Dehydrogenase Deficiency |
|
76 |
Multiple Sclerosis |
|
77 |
Multiple System Atrophy |
|
78 |
Myotonic Dystrophy |
|
79 |
N-乙酰谷氨酸合成酶缺乏症 |
N-acetylglutamate Synthase Deficiency |
80 |
Neonatal Diabetes Mellitus |
|
81 |
Neuromyelitis Optica |
|
82 |
Niemann-Pick Disease |
|
83 |
Non-Syndromic Deafness |
|
84 |
Noonan Syndrome |
|
85 |
Ornithine Transcarbamylase Deficiency |
|
86 |
Osteogenesis Imperfecta (Brittle Bone Disease) |
|
87 |
Parkinson Disease (Young-onset , Early-onset) |
|
88 |
Paroxysmal Nocturnal Hemoglobinuria |
|
89 |
Peutz-Jeghers Syndrome |
|
90 |
Phenylketonuria |
|
91 |
POEMS Syndrome |
|
92 |
Porphyria |
|
93 |
Prader-Willi Syndrome |
|
94 |
Primary Combined Immune Deficiency |
|
95 |
Primary Hereditary Dystonia |
|
96 |
Primary Light Chain Amyloidosis |
|
97 |
Progressive Familial Intrahepatic Cholestasis |
|
98 |
Progressive Muscular Dystrophy |
|
99 |
Propionic Acidemia |
|
100 |
Pulmonary Alveolar Proteinosis |
|
101 |
Pulmonary Cystic Fibrosis |
|
102 |
Retinitis Pigmentosa |
|
103 |
Retinoblastoma |
|
104 |
Severe Congenital Neutropenia |
|
105 |
Severe Myoclonic Epilepsy in Infancy (Dravet Syndrome) |
|
106 |
Sickle Cell Disease |
|
107 |
Silver-Russell综合征 |
Silver-Russell Syndrome |
108 |
谷固醇血症 |
Sitosterolemia |
109 |
Spinal and Bulbar Muscular Atrophy (Kennedy Disease) |
|
110 |
Spinal Muscular Atrophy |
|
111 |
Spinocerebellar Ataxia |
|
112 |
Systemic Sclerosis |
|
113 |
Tetrahydrobiopterin Deficiency |
|
114 |
Tuberous Sclerosis Complex |
|
115 |
Tyrosinemia |
|
116 |
Very Long Chain Acyl-CoA Dehydrogenase Deficiency |
|
117 |
Williams Syndrome |
|
118 |
Wiskott-Aldrich Syndrome |
|
119 |
X-linked Agammaglobulinemia |
|
120 |
X-linked Adrenoleukodystrophy |
|
121 |
X-linked Lymphoproliferative Disease |
国卫医政发〔2023〕26号
各省、自治区、直辖市及新疆生产建设兵团卫生健康委、科技厅(委、局)、工业和信息化主管部门、药品监督管理部门、中医药主管部门,军队各级卫生部门:
为深入贯彻落实中共中央办公厅、国务院办公厅《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》,进一步加强我国罕见病管理,提高罕见病诊疗水平,维护罕见病患者健康权益,根据《罕见病目录制订工作程序》,国家卫生健康委等6部门联合制定了《第二批罕见病目录》。现印发给你们,供各部门在工作中参考使用。
国家卫生健康委 科技部
工业和信息化部 国家药监局
国家中医药局 中央军委后勤保障部
2023年9月18日
第二批罕见病目录
序号 |
疾病名称(中文) |
疾病名称(英文) |
1 |
Achondroplasia |
|
2 |
Acquired hemophilia |
|
3 |
肢端肥大症 |
Acromegaly |
4 |
Adult-onset Still disease |
|
5 |
Alagille syndrome |
|
6 |
α-1-抗胰蛋白酶缺乏症 |
Alpha-1-antitrypsin deficiency |
7 |
ANCA-associated vasculitis |
|
8 |
Bardet-Biedl syndrome |
|
9 |
白塞病/贝赫切特综合征 |
Behçet's disease |
10 |
蓝色橡皮疱样痣 |
Blue rubber bleb nevus |
11 |
CDKL5缺乏症 |
CDKL5-deficiency disorder |
12 |
Choroideremia |
|
13 |
Chronic inflammatory demyelinating polyneuropathy |
|
14 |
肾透明细胞肉瘤 |
Clear cell sarcoma of kidney |
15 |
冷凝集素病 |
Cold agglutinin disease |
16 |
先天性胆道闭锁 |
Congenital biliary atresia |
17 |
先天性凝血因子VII缺乏症 |
Congenital factor VII deficiency |
18 |
冷吡啉(冷炎素)相关周期性综合征/NLRP3相关自身炎症性疾病 |
Cryopyrin associated periodic syndrome/ NLRP3-associated systemic autoinflammatory disease |
19 |
皮肤神经内分泌癌(梅克尔细胞癌) |
Cutaneous neuroendocrine carcinoma(Merkel cell carcinoma) |
20 |
皮肤T细胞淋巴瘤 |
Cutaneous T-cell lymphomas |
21 |
Cystinosis |
|
22 |
隆突性皮肤纤维肉瘤 |
Dermatofibrosarcoma protuberans |
23 |
嗜酸性粒细胞性胃肠炎 |
Eosinophilic gastroenteritis |
24 |
上皮样肉瘤 |
Epithelioid sarcoma |
25 |
面肩肱型肌营养不良症 |
Facioscapulohumeral muscular dystrophy |
26 |
Familial hemophagocytic lymphohistiocytosis |
|
27 |
Familial adenomatous polyposis |
|
28 |
Fibrodysplasia ossificans progressiva |
|
29 |
Fragile X syndrome |
|
30 |
Gangliosidosis |
|
31 |
Gastroenteropancreatic neuroendocrine neoplasm |
|
32 |
胃肠间质瘤 |
Gastrointestinal stromal tumor |
33 |
Generalized pustular psoriasis |
|
34 |
Genetic hypoparathyroidism |
|
35 |
Giant cell arteritis |
|
36 |
Giant cell tumor of bone |
|
37 |
Glanzmann thrombasthenia |
|
38 |
胶质母细胞瘤 |
Glioblastoma |
39 |
高林综合征 |
Gorlin syndrome |
40 |
Hidradenitis suppurativa |
|
41 |
早老症 |
Hutchinson-Gilford progeria syndrome |
42 |
Inflammatory myofibroblastic tumor |
|
43 |
Leber congenital amaurosis |
|
44 |
Lennox-Gastaut syndrome |
|
45 |
Limbal stem cell deficiency |
|
46 |
恶性高热 |
Malignant hyperthermia |
47 |
Malignant pleural mesothelioma |
|
48 |
黑色素瘤 |
Melanoma |
49 |
Metachromatic leukodystrophy |
|
50 |
单基因非综合征性肥胖 |
Monogenic non-syndromic obesity |
51 |
Multiple endocrine neoplasia |
|
52 |
Narcolepsy |
|
53 |
Neuroblastoma |
|
54 |
Neurofibromatosis |
|
55 |
Neuronal ceroid lipofuscinosis |
|
56 |
Neurotrophic keratitis |
|
57 |
骨肉瘤 |
Osteosarcoma |
58 |
天疱疮 |
Pemphigus |
59 |
新生儿持续肺动脉高压 |
Persistent pulmonary hypertension of the newborn |
60 |
Pheochromocytoma |
|
61 |
PIK3CA related overgrowth syndrome |
|
62 |
Polycythaemia vera |
|
63 |
原发性胆汁性胆管炎 |
Primary biliary cholangitis |
64 |
原发性生长激素缺乏症 |
Primary growth hormone deficiency |
65 |
原发性胰岛素样生长因子-1缺乏症 |
Primary IGF1 deficiency |
66 |
原发性免疫缺陷 |
Primary immunodeficiency |
67 |
Primary myelofibrosis |
|
68 |
原发性硬化性胆管炎 |
Primary sclerosing cholangitis |
69 |
进行性纤维化性间质性肺疾病 |
Progressive fibrosing interstitial lung disease |
70 |
复发性心包炎 |
Recurrent pericarditis |
71 |
早产儿视网膜病 |
Retinopathy of prematurity |
72 |
Rett综合征 |
Rett syndrome |
73 |
短肠综合征 |
Short bowel syndrome |
74 |
Systemic juvenile idiopathic arthritis |
|
75 |
系统性肥大细胞增多症 |
Systemic mastocytosis |
76 |
大动脉炎/多发性大动脉炎 |
Takayasu arteritis |
77 |
Tenosynovial giant cell tumor/Pigmented villonodular synovitis |
|
78 |
Thalassemia major |
|
79 |
Thrombotic thrombocytopenic purpura |
|
80 |
Transthyretin amyloidosis |
|
81 |
Tumor necrosis factor receptor associated periodic syndrome |
|
82 |
肿瘤相关骨软化症 |
Tumor-induced osteomalacia |
83 |
Von Hippel-Lindau syndrome |
|
84 |
Von Willebrand disease type3 |
|
85 |
Waldenström macroglobulinemia/ Lymphoplasmacytic lymphoma |
|
86 |
West syndrome/Infantile spasms syndrome |
信源:国家卫健委官网
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
#罕见病#
27